| Literature DB >> 31866424 |
Meaghan H Hancock1, Lindsey B Crawford1, Andrew H Pham1, Jennifer Mitchell1, Hillary M Struthers1, Andrew D Yurochko2, Patrizia Caposio1, Jay A Nelson3.
Abstract
Infection with human cytomegalovirus (HCMV) remains a significant cause of morbidity and mortality following hematopoietic stem cell transplant (HSCT) because of various hematologic problems, including myelosuppression. Here, we demonstrate that latently expressed HCMV miR-US5-2 downregulates the transcriptional repressor NGFI-A binding protein (NAB1) to induce myelosuppression of uninfected CD34+ hematopoietic progenitor cells (HPCs) through an increase in TGF-β production. Infection of HPCs with an HCMVΔmiR-US5-2 mutant resulted in decreased TGF-β expression and restoration of myelopoiesis. In contrast, we show that infected HPCs are refractory to TGF-β signaling as another HCMV miRNA, miR-UL22A, downregulates SMAD3, which is required for maintenance of latency. Our data suggest that latently expressed viral miRNAs manipulate stem cell homeostasis by inducing secretion of TGF-β while protecting infected HPCs from TGF-β-mediated effects on viral latency and reactivation. These observations provide a mechanism through which HCMV induces global myelosuppression following HSCT while maintaining lifelong infection in myeloid lineage cells.Entities:
Keywords: CD34(+) hematopoietic progenitor cells; NAB1; SMAD3; TGF-β; hematopoiesis; human cytomegalovirus; latency; miRNAs; myelosuppression
Mesh:
Substances:
Year: 2019 PMID: 31866424 PMCID: PMC6952548 DOI: 10.1016/j.chom.2019.11.013
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023